LivaNova Drives For Certainty And Speed: Q&A With CEO Damien McDonald
Damien McDonald has been CEO of LivaNova since January 2017. Speaking to In Vivo during the group’s Investor Day in mid-September, he described his efforts to transform the group and leverage its innovative cardiac surgery and neuromod technologies, and conveyed his drive to attract and develop talent.
You may also be interested in...
Medical innovator LivaNova has a new stated focus: it won’t go outside the head and the heart when it comes to potential M&A and technology development projects. It has set out short- and longer-term solutions to boost sales and/or profitability in its neuromodulation and cardio franchises. What is certain is that eight months into his tenure as CEO, Damien McDonald is stamping his imprint all over LivaNova.
Entrepreneur Carlo Rivis, one of In Vivo’s Rising Leaders, brought his disruptive innovation approaches to in-silico trials and digital avatar developer Computational Life, and now he is doing the same at Innovation Discovery.
COVID-19 is of no lesser importance to the UK medtech industry, but attention is now refocusing on Brexit, future regulation and trade deals.